Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program
Identification
- Public canonical key
- radar:r-83c9acc00ddefe913975e1d6eb95bbb1
- Authors
- Mădălina Cristina Leanca · Gelu Onose · Georgiana Nicolae · Elena Neagu · Daniela Vasile · Ecaterina Bercu · Oana Mirabela Balanescu · Andrei Căpitănescu · Constantin Munteanu · C. Popescu · Andrada Mirea
- Reported year
- 2026
- Reported language
- en
- Source type
- article
- First detected
- 2026-11-13T12:44:36.165909+00:00
- Last metadata observation
- 2026-11-13T12:44:36.165909+00:00
- Last HTTP verification
- Not checked
Institutions reported by the source
Carol Davila University of Medicine and Pharmacy · Spitalului Clinic de Urgență pentru Copii Maria Sklodowska Curie · Grigore T. Popa University of Medicine and Pharmacy
Reported affiliation countries
RO
Documentary abstract — original language
Spinal muscular atrophy (SMA) is a severe genetic neuromuscular disorder caused by bi-allelic deletions or pathogenic SMN1 variants. Early diagnosis through neonatal screening is essential for timely therapeutic intervention, significantly improving clinical outcomes. In August 2022, a pilot neonatal screening program for SMA was launched in Romania, aiming to assess feasibility and impact. Objectives are to present the preliminary results of the ongoing SMA neonatal screening pilot program in Romania, evaluating its effectiveness in early detection and referral for treatment. The program started in August 2022 with four maternity hospitals and has progressively expanded to 28 maternity hospitals nationwide. Dried blood spot samples from newborns were analyzed for SMN1 gene deletions using real-time PCR. Positive results were confirmed through genetic testing, and affected infants, along with their families, were referred for further medical evaluation and early therapeutic intervention. Approximately 60,000 newborns have been screened since the program’s inception, and 12 newborns tested positive for SMN1 deletions, resulting in an estimated incidence rate of 1 in 5125 live births. All confirmed cases were promptly referred for specialized care, with early access to disease-modifying therapies. The program has faced challenges in logistics, parental awareness, and equitable access to treatment, but its expansion from 4 to 28 maternities demonstrates increasing feasibility, suitability, and acceptance. Conclusions: The Romanian pilot neonatal screening program for SMA has successfully identified affected infants early, proving its feasibility and clinical impact. The ongoing expansion suggests a strong foundation for a future national program, which could significantly improve early SMA diagnosis and patient outcomes in Romania.
Identifiers
- OPENALEX
- https://openalex.org/W7127181044
- DOI
- 10.3390/ijns12010006
- PMID
- https://pubmed.ncbi.nlm.nih.gov/41718420
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/12957999
Documentary context
- Documentary family
- article
- Source-reported types
- article
- Publishers
- Multidisciplinary Digital Publishing Institute
Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.
Sources
OpenAlex · Record 1
Cite this reference
Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. 2026. https://doi.org/10.3390/ijns12010006
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.
- APA
- Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. (2026). Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. https://doi.org/10.3390/ijns12010006
- Chicago
- Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. 2026. https://doi.org/10.3390/ijns12010006
- ISO 690
- Mădălina Cristina Leanca; Gelu Onose; Georgiana Nicolae; Elena Neagu; Daniela Vasile; Ecaterina Bercu; Oana Mirabela Balanescu; Andrei Căpitănescu; Constantin Munteanu; C. Popescu; Andrada Mirea. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. 2026. https://doi.org/10.3390/ijns12010006
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR Global Rights of Nature Legal Library. Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-83c9acc00ddefe913975e1d6eb95bbb1/ · Last HTTP verification: not performed
Research dossiers and documentary relations
Source roles
Bibliographic / original publication source · https://doi.org/10.3390/ijns12010006
An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.
Documentary status
Relevance pending
Library
This identity is not yet included in the Legal Library.